Inflammation regulates TMPRSS6 expression via STAT5

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Meynard, Delphine ^a   Sun, Chia Chi ^a   Wu, Qifang ^a   Chen, Wenjie ^a   Chen, Shanzhuo ^a   Nelson, Caroline N ^b   Waters, Michael J ^b   Babitt, Jodie L ^a   Lin, Herbert Y ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; HEPCIDIN; INTERLEUKIN 6; MATRIPTASE 2; MEMBRANE PROTEIN; MESSENGER RNA; SERINE PROTEINASE; SMAD PROTEIN; STAT5 PROTEIN; TMPRSS6 PROTEIN, HUMAN;

ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; DOWN REGULATION; DRUG EFFECTS; GENETICS; HUMAN; INFLAMMATION; MALE; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL LINE, TUMOR; DOWN-REGULATION; HEPCIDINS; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MEMBRANE PROTEINS; MICE, INBRED C57BL; MODELS, BIOLOGICAL; PHOSPHORYLATION; RNA, MESSENGER; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION; SMAD PROTEINS; STAT5 TRANSCRIPTION FACTOR;

EID: 84893431464     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082127     Document Type: Article

References (27)

1. Du X, She E, Gelbart T, Truksa J, Lee P, et al. (2008) The serine protease TMPRSS6 is required to sense iron deficiency. Science 320: 1088-1092. (Pubitemid 351929552)
2. Finberg KE, Heeney MM, Campagna DR, Aydinok Y, Pearson HA, et al. (2008) Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet 40: 569-571. (Pubitemid 351601217)
3. Benyamin B, Ferreira MA, Willemsen G, Gordon S, Middelberg RP, et al. (2009) Common variants in TMPRSS6 are associated with iron status and erythrocyte volume. Nat Genet 41: 1173-1175.
4. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, et al. (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306: 2090-2093. (Pubitemid 40007660)
5. Meynard D, Kautz L, Darnaud V, Canonne-Hergaux F, Coppin H, et al. (2009) Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet 41: 478-481.
6. Silvestri L, Pagani A, Nai A, De Domenico I, Kaplan J, et al. (2008) The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab 8: 502-511.
7. Zhang AS, Anderson SA, Wang J, Yang F, Demaster K, et al. (2010) Suppression of hepatic hepcidin expression in response to acute iron deprivation is associated with an increase of matripatase-2 protein. Blood.
8. Maurer E, Gutschow M, Stirnberg M (2012) Matriptase-2 (TMPRSS6) is directly up-regulated by hypoxia inducible factor-1: identification of a hypoxia-responsive element in the TMPRSS6 promoter region. Biol Chem 393: 535-540.
9. Peng H, Truksa J, Lee P (2010) EPO-mediated reduction in Hamp expression in vivo corrects iron deficiency anaemia in TMPRSS6 deficiency. Br J Haematol 151: 106-109.
10. Meynard D, Vaja V, Sun CC, Corradini E, Chen S, et al. (2011) Regulation of TMPRSS6 by BMP6 and iron in human cells and mice. Blood 118: 747-756.
11. De Domenico I, Zhang TY, Koening CL, Branch RW, London N, et al. (2010) Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J Clin Invest 120: 2395-2405.
12. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, et al. (2004) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113: 1271-1276. (Pubitemid 39069926)
13. Verga Falzacappa MV, Vujic Spasic M, Kessler R, Stolte J, Hentze MW, et al. (2007) STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 109: 353-358. (Pubitemid 46053077)
14. Casanovas G, Mleczko-Sanecka K, Altamura S, Hentze MW, Muckenthaler MU (2009) Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD. J Mol Med (Berl) 87: 471-480.
15. Besson-Fournier C, Latour C, Kautz L, Bertrand J, Ganz T, et al. (2012) Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1/5/8 signaling. Blood 120: 431-439.
16. Alexander C, Rietschel ET (2001) Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 7: 167-202. (Pubitemid 32894573)
17. Deschemin JC, Vaulont S (2013) Role of hepcidin in the setting of hypoferremia during acute inflammation. PLoS One 8: e61050.
18. Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, et al. (2006) Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 38: 531-539.
19. Ehret GB, Reichenbach P, Schindler U, Horvath CM, Fritz S, et al. (2001) DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites. J Biol Chem 276: 6675-6688.
20. Grigorov I, Lazic T, Cvetkovic I, Milosavljevic T, Petrovic M (2001) Opposite nuclear level and binding activity of STAT5B and STAT3 proteins with rat haptoglobin gene under normal and turpentine induced acute phase conditions. Mol Biol Rep 28: 217-222. (Pubitemid 34718395)
21. Kerenyi MA, Grebien F, Gehart H, Schifrer M, Artaker M, et al. (2008) Stat5 regulates cellular iron uptake of erythroid cells via IRP-2 and TfR-1. Blood 112: 3878-3888.
22. Rane SG, Reddy EP (2002) JAKs, STATs and Src kinases in hematopoiesis. Oncogene 21: 3334-3358. (Pubitemid 34587707)
23. Sasaki Y, Noguchi-Sasaki M, Yasuno H, Yorozu K, Shimonaka Y (2012) Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice. Int J Hematol 96: 692-700.
24. Nai A, Pagani A, Mandelli G, Lidonnici MR, Silvestri L, et al. (2012) Deletion of Tmprss6 attenuates the phenotype in a mouse model of beta-thalassemia. Blood.
25. Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, et al. (2002) Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A 99: 4596-4601. (Pubitemid 34286030)
26. Weiss G, Goodnough LT (2005) Anemia of chronic disease. N Engl J Med 352: 1011-1023.
27. Sun CC, Vaja V, Babitt JL, Lin HY (2012) Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation. Am J Hematol 87: 392-400.